Prudential Financial’s Tevogen Bio Holdings TVGN Stock Holding History

Prudential Financial’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-230	Closed	-$3.81K	–	2529
2025 Q4	$3.81K	Buy	+230	New	+$5.98K	﹤0.01%	2208

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Prudential Financial's TVGN Position: Q1 2026 in Review

Prudential Financial sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 230 shares — an estimated $3.81K sold.

Prudential Financial first reported a position in TVGN in Q4 2025 and held it in 1 quarter. The position peaked at $3.81K in Q4 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

Prudential Financial reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
Prudential Financial sold 230 Tevogen Bio Holdings shares in Q1 2026, an estimated $3.81K.
Prudential Financial first reported a position in Tevogen Bio Holdings in Q4 2025 and held it in 1 quarter.
Prudential Financial's Tevogen Bio Holdings position peaked at $3.81K in Q4 2025.
30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.